Teva Pharmaceutical Industries Limited: From Clinical Trial Efficacy to Real-World Effectiveness First AJOVY - (fremanezumab) Data from European Real World Evidence Program
Ratiopharm-Mutter Teva schwächelt im zweiten Quartal | Nachricht | finanzen.net